Patent · US Active

Pyridone derivative comprising heteroatomic ring butane substituent, for treating fibrosis and inflammatory diseases

US10604513B2 · kind B2 · utility

0Cited by

2References

21Claims

0Family size

Assignee

SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT COMPANY, LTD. · CN

Inventors

Neng-Yang Shih · Lexington, US
Bin Chen · Shanghai, CN
Lei Zhang · Beijing, CN
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Apr 14, 2017
Grant date	Mar 31, 2020
Priority date	—
Expiry date	Apr 14, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a compound for treating fibrosis-related diseases, and specifically disclosed are the compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.